McElyea, Samantha D <br/><br/>
Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome.  [electronic resource] 

 -  Human molecular genetics  11 2016 
 - 4856-4869 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1460-2083 
<br/><br/><label>Standard No.: </label>10.1093/hmg/ddw309  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Catechin--analogs & derivatives<br/>Craniofacial Abnormalities--enzymology<br/>Disease Models, Animal<br/>Down Syndrome--enzymology<br/>Female<br/>Gene Dosage<br/>Mice<br/>Phenotype<br/>Phosphorylation<br/>Pregnancy<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Dyrk Kinases